The GlaxoSmithKline (GSK) Clinical Study Register provides an easily accessible repository of data from GSK-Sponsored Clinical Studies, supplementing communication in journals, at scientific meetings, in letters to healthcare professionals, and in approved prescribing information. It is important to emphasise that approved prescribing information must continue to guide appropriate use of GSK medicines. This information may vary from country to country. Before prescribing any product mentioned in the Register, Healthcare Professionals should consult prescribing information approved in their country.
GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
This register helps you to:
The Register provides summary protocol information for GSK sponsored clinical studies. Clinical studies are categorised as recruiting, not yet recruiting, no longer recruiting, terminated, or completed.
The register provides scientific, non-promotional summaries of clinical studies in a consistent format, irrespective of whether the results may be viewed as positive or negative for GSK medicines.
The Register includes clinical studies of marketed products and other studies that are relevant to patient care.
GSK has many alliances with other pharmaceutical companies. As part of these alliances, GSK may not have been the regulatory sponsor of all clinical studies for a product and therefore the results of such studies may not appear on this register. Please see other public registries such as www.ClinicalTrials.gov or EU Clinical Trials Register for any study disclosures from our alliance companies.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.